{"AllianceGenome": "10860", "HGNC": "10860", "MIM": "109675", "_id": "6480", "_version": 1, "accession": {"genomic": ["AC007488.15", "AC007690.12", "CH471052.2", "CP068275.2", "FB715160.1", "KF510844.1", "NC_000003.12", "NC_060927.1"], "protein": ["AAH31476.1", "AAH40009.1", "BAF85568.1", "BAG34960.1", "CAA01327.1", "CAA01686.1", "CAA35111.1", "CAA38246.1", "CAA44634.1", "CAS91678.1", "EAW78158.1", "EAW78159.1", "EAW78160.1", "EAW78161.1", "EAW78162.1", "EAW78163.1", "EAW78164.1", "NP_001340845.1", "NP_003023.1", "NP_775323.1", "NP_775324.1", "P15907.1"], "rna": ["A17362.1", "A23699.1", "AF007133.1", "AK128726.1", "AK292879.1", "AK312023.1", "BC031476.1", "BC040009.1", "DB152155.1", "DB235666.1", "L11720.1", "NM_001353916.2", "NM_003032.3", "NM_173216.2", "NM_173217.2", "U67849.1", "X17247.1", "X54363.1", "X62822.1"], "translation": [{"protein": "NP_001340845.1", "rna": "NM_001353916.2"}, {"protein": "AAH40009.1", "rna": "BC040009.1"}, {"protein": "CAA38246.1", "rna": "X54363.1"}, {"protein": "NP_775323.1", "rna": "NM_173216.2"}, {"protein": "CAA44634.1", "rna": "X62822.1"}, {"protein": "CAA01686.1", "rna": "A23699.1"}, {"protein": "CAA35111.1", "rna": "X17247.1"}, {"protein": "BAG34960.1", "rna": "AK312023.1"}, {"protein": "AAH31476.1", "rna": "BC031476.1"}, {"protein": "NP_003023.1", "rna": "NM_003032.3"}, {"protein": "NP_775324.1", "rna": "NM_173217.2"}, {"protein": "BAF85568.1", "rna": "AK292879.1"}, {"protein": "CAA01327.1", "rna": "A17362.1"}]}, "alias": ["CDw75", "SIAT1", "ST6GalI", "ST6N"], "ec": "2.4.3.1", "ensembl": {"gene": "ENSG00000073849", "protein": ["ENSP00000169298", "ENSP00000388789", "ENSP00000388928", "ENSP00000389337", "ENSP00000390793", "ENSP00000397273", "ENSP00000399525", "ENSP00000400547", "ENSP00000403063", "ENSP00000407631", "ENSP00000411518", "ENSP00000412221", "ENSP00000412821", "ENSP00000414504", "ENSP00000415886", "ENSP00000416163", "ENSP00000503457", "ENSP00000504448"], "transcript": ["ENST00000169298", "ENST00000416235", "ENST00000417392", "ENST00000423451", "ENST00000427315", "ENST00000430309", "ENST00000438590", "ENST00000440338", "ENST00000442023", "ENST00000446170", "ENST00000448044", "ENST00000448408", "ENST00000448449", "ENST00000455441", "ENST00000457772", "ENST00000458216", "ENST00000463542", "ENST00000464827", "ENST00000468614", "ENST00000470633", "ENST00000485105", "ENST00000676633", "ENST00000676786", "ENST00000677292"], "translation": [{"protein": "ENSP00000169298", "rna": "ENST00000169298"}, {"protein": "ENSP00000412221", "rna": "ENST00000457772"}, {"protein": "ENSP00000397273", "rna": "ENST00000455441"}, {"protein": "ENSP00000412821", "rna": "ENST00000427315"}, {"protein": "ENSP00000503457", "rna": "ENST00000677292"}, {"protein": "ENSP00000400547", "rna": "ENST00000458216"}, {"protein": "ENSP00000399525", "rna": "ENST00000430309"}, {"protein": "ENSP00000407631", "rna": "ENST00000417392"}, {"protein": "ENSP00000416163", "rna": "ENST00000438590"}, {"protein": "ENSP00000390793", "rna": "ENST00000448408"}, {"protein": "ENSP00000504448", "rna": "ENST00000676633"}, {"protein": "ENSP00000388928", "rna": "ENST00000440338"}, {"protein": "ENSP00000389337", "rna": "ENST00000448044"}, {"protein": "ENSP00000414504", "rna": "ENST00000416235"}, {"protein": "ENSP00000411518", "rna": "ENST00000423451"}, {"protein": "ENSP00000388789", "rna": "ENST00000446170"}, {"protein": "ENSP00000415886", "rna": "ENST00000448449"}, {"protein": "ENSP00000403063", "rna": "ENST00000442023"}], "type_of_gene": "protein_coding"}, "entrezgene": "6480", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 9.65010419, "exp_mis": 129.1919043, "exp_syn": 55.101725, "lof_z": 2.75832242263691, "mis_z": 0.223421587175014, "mu_lof": 6.66768221169e-07, "mu_mis": 1.12174830572e-05, "mu_syn": 4.67831086664e-06, "n_lof": 1.0, "n_mis": 124.0, "n_syn": 51.0, "p_li": 0.814435677774412, "p_null": 0.000951119924015963, "p_rec": 0.184613202301572, "syn_z": 0.342557843347506}, "bp": 1221, "cds_end": 186793591, "cds_start": 186760491, "n_exons": 5, "nonpsych": {"exp_lof": 8.6310976, "exp_mis": 116.8279656, "exp_syn": 49.7691946, "lof_z": 2.5509736634288, "mis_z": 0.225297014026345, "mu_lof": 6.66768221169e-07, "mu_mis": 1.12174830572e-05, "mu_syn": 4.67831086664e-06, "n_lof": 1.0, "n_mis": 112.0, "n_syn": 46.0, "p_li": 0.773804089594391, "p_null": 0.00200356833301005, "p_rec": 0.224192342072599, "syn_z": 0.336380846579487}, "nontcga": {"exp_lof": 8.86803904, "exp_mis": 118.8465034, "exp_syn": 50.68352615, "lof_z": 2.60635741811891, "mis_z": 0.0386852419977328, "mu_lof": 6.66768221169e-07, "mu_mis": 1.12174830572e-05, "mu_syn": 4.67831086664e-06, "n_lof": 1.0, "n_mis": 118.0, "n_syn": 46.0, "p_li": 0.772967502532066, "p_null": 0.00166329989063707, "p_rec": 0.225369197577296, "syn_z": 0.416545226159757}, "transcript": "ENST00000169298.3"}, "exons": [{"cdsend": 187075803, "cdsstart": 187042703, "chr": "3", "position": [[187038717, 187038873], [187042653, 187043310], [187051248, 187051346], [187072848, 187072947], [187074158, 187074333], [187075561, 187078553]], "strand": 1, "transcript": "NM_001353916", "txend": 187078553, "txstart": 187038717}, {"cdsend": 187075803, "cdsstart": 187042703, "chr": "3", "position": [[187021854, 187022004], [187038741, 187038873], [187042653, 187043310], [187051248, 187051346], [187072848, 187072947], [187074158, 187074333], [187075561, 187078553]], "strand": 1, "transcript": "NM_003032", "txend": 187078553, "txstart": 187021854}, {"cdsend": 187075803, "cdsstart": 187042703, "chr": "3", "position": [[186930525, 186930834], [186963784, 186963926], [187038741, 187038873], [187042653, 187043310], [187051248, 187051346], [187072848, 187072947], [187074158, 187074333], [187075561, 187078553]], "strand": 1, "transcript": "NM_173216", "txend": 187078553, "txstart": 186930525}, {"cdsend": 187075803, "cdsstart": 187051334, "chr": "3", "position": [[186930525, 186930834], [186963784, 186963926], [187038741, 187038873], [187051248, 187051346], [187072848, 187072947], [187074158, 187074333], [187075561, 187078553]], "strand": 1, "transcript": "NM_173217", "txend": 187078553, "txstart": 186930525}], "exons_hg19": [{"cdsend": 186793591, "cdsstart": 186760491, "chr": "3", "position": [[186756505, 186756661], [186760441, 186761098], [186769036, 186769134], [186790636, 186790735], [186791946, 186792121], [186793349, 186796341]], "strand": 1, "transcript": "NM_001353916", "txend": 186796341, "txstart": 186756505}, {"cdsend": 186793591, "cdsstart": 186760491, "chr": "3", "position": [[186739642, 186739792], [186756529, 186756661], [186760441, 186761098], [186769036, 186769134], [186790636, 186790735], [186791946, 186792121], [186793349, 186796341]], "strand": 1, "transcript": "NM_003032", "txend": 186796341, "txstart": 186739642}, {"cdsend": 186793591, "cdsstart": 186760491, "chr": "3", "position": [[186648314, 186648623], [186681572, 186681714], [186756529, 186756661], [186760441, 186761098], [186769036, 186769134], [186790636, 186790735], [186791946, 186792121], [186793349, 186796341]], "strand": 1, "transcript": "NM_173216", "txend": 186796341, "txstart": 186648314}, {"cdsend": 186793591, "cdsstart": 186769122, "chr": "3", "position": [[186648314, 186648623], [186681572, 186681714], [186756529, 186756661], [186769036, 186769134], [186790636, 186790735], [186791946, 186792121], [186793349, 186796341]], "strand": 1, "transcript": "NM_173217", "txend": 186796341, "txstart": 186648314}], "generif": [{"pubmed": 12499376, "text": "ST6Gal I sialyltransferase has a role in regulating galectin-1-induced CD45 clustering, phosphatase modulation, and T cell death"}, {"pubmed": 12798701, "text": "Expression of alpha 2,6-sialyltransferase ST6Gal I is enhanced in cervical squamous cell carcinoma."}, {"pubmed": 12878221, "text": "Transcriptional activation of beta-galactoside alpha2,6-sialyltransferase in colon adenocarcinoma cells."}, {"pubmed": 12931020, "text": "High levels of ST6GAL-I in the tumor tissue correlated with secondary local tumor recurrence (p = 0.005; p = 0.012)."}, {"pubmed": 12943659, "text": "specific kinase enzymes have important roles in the expression and catalytic activity of the alpha2,6 STN (ST6N) isozyme"}, {"pubmed": 14514712, "text": "Neoplastic transformation but not cirrhosis can alter the process of alpha2,6-sialylation of liver glycoproteins."}, {"pubmed": 16053379, "text": "sialyltransferases expression and activity are increased in Grave's disease"}, {"pubmed": 16192407, "text": "the presence of alpha2,6-linked sialic acid added by ST6Gal.I on membrane glycoconjugates increases the binding to extracellular matrix components, resulting in a membrane stabilization of beta1 integrins, further strengthening the binding"}, {"pubmed": 16319516, "text": "ST6Gal I is upregulated in tumor and transitional tissues from colorectal cancer patients"}, {"pubmed": 17441333, "text": "siRNA targeting to ST6Gal I can effectively downregulate the ST6Gal I expression in HeLa cell and further lead to the decline of cell adhesion and invasiveness to ECM."}, {"pubmed": 17697868, "text": "Appearance of asialoconjugates in alcoholics is possibly due to the down-regulation of ST6GalI gene expression."}, {"pubmed": 17897958, "text": "soluble ST6Gal I produced by BACE1 plays, at least in part, a role in the sialylation of soluble glycoproteins"}, {"pubmed": 18650447, "text": "Proteolytic shedding of ST6Gal-I by BACE1 regulates the glycosylation and function of alpha4beta1 integrins"}, {"pubmed": 19013288, "text": "Alcohol-mediated down-regulation of hepatic ST6Gal1 gene leads to defective intracellular lipid and lipoprotein transport, which in turn may contribute to alcoholic steatosis."}, {"pubmed": 19150807, "text": "There are two possible mechanisms for the upregulation of plasma ST6Gal I in hepatopathological situations: one accompanied by acute phase reactions to increase hepatic ST6Gal I expression and the other triggered by oxidative stress in the liver."}, {"pubmed": 19170967, "text": "Activity of alpha2,6-sialyltransferase and its gene expression in peripheral B lymphocytes in patients with IgA nephropathy."}, {"pubmed": 19413643, "text": "DBA.44(CD76) patterns of expression would help the pathologist to recognize the morphological pattern of the different subgroups of splenic marginal zone lymphomas"}, {"pubmed": 19709745, "text": "ST6Gal I and ST3Gal V were positively correlated with the high risk of pediatric acute leukemia."}, {"pubmed": 20003255, "text": "enhanced tumour ST6Gal I activity and an increased CDw75 expression may play a role in malignant transformation of colorectal cancer"}, {"pubmed": 20127017, "text": "Adhesion of ST6Gal I-mediated human colon cancer cells to fibronectin contributes to cell survival by integrin beta1-mediated paxillin and AKT activation."}, {"pubmed": 20379614, "text": "Clinical trial of gene-disease association and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 20656882, "text": "ST6Gal I is responsible for ST2H antigen biosynthesis in human colon cancer cells."}, {"pubmed": 21140242, "text": "These results indicated that gastric cancer tissues expressed high levels of alpha 2,3-linked sialic acid residues, ST3Gal IV, and ST6Gal I."}, {"pubmed": 21147760, "text": "the occurrence of CD75s- and iso-CD75s-gangliosides in tumor tissues is largely independent of the transcriptional expression of ST6GAL1 and ST3GAL6"}, {"pubmed": 21550977, "text": "Sialylation of the Fas death receptor by ST6Gal-I provides protection against Fas-mediated apoptosis in colon carcinoma cells."}, {"pubmed": 21778787, "text": "CDw75 expression in colorectal tumoural tissue was correlated with growth pattern (p = 0.044), Dukes stage (p = 0.002), TNM stage (p = 0.020) and distant metastasis (p = 0.005)."}, {"pubmed": 21930713, "text": "ST6Gal-I regulates macrophage apoptosis via alpha2-6 sialylation of the TNFR1 death receptor."}, {"pubmed": 22449099, "text": "Our results suggest that soluble ST6Gal may participate in cancer progression and metastasis prior to being secreted from cancer cells"}, {"pubmed": 23358684, "text": "ST6Gal-I protein expression is upregulated in epithelial tumors."}, {"pubmed": 23504322, "text": "the suppressive role of Necl-2 in the HRG-induced ErbB2/ErbB3 signaling is regulated by miR-199a at least through the reduction of the ST6GAL1-catalyzed sialylation of Necl-2"}, {"pubmed": 23549466, "text": "the high expression of ST3Gal I and ST6Gal I, in skin tumors, is associated with tumors with greater potential for invasion and metastasis, as in the case of squamous cell carcinoma, and this may be related to their behavior."}, {"pubmed": 23999306, "text": "A large glycan from a symmetry mate localizes to the active site of ST6Gal-I in an orientation compatible with catalysis. The glycan binding mode can be generalized to any glycoprotein that is a substrate of ST6Gal-I."}, {"pubmed": 24606438, "text": "The study detected only one allele of each polymorphism in the ST6GAL1P1 promoter."}, {"pubmed": 25344606, "text": "ST6GAL1 promotes TGF-beta-dependent epithelial-mesenchymal transition"}, {"pubmed": 25465919, "text": "Study characterizes ST6GAL1 expression loss caused by aberrant ST6GAL1 promoter methylation potentially indicating a tumor suppressive role in bladder carcinogenesis."}, {"pubmed": 25566667, "text": "The lymphocyte levels of NEU1 and ST6GAL1 mRNA expression are significantly increased in erythremia."}, {"pubmed": 25573487, "text": "Sialylation by beta-galactoside alpha-2,6-sialyltransferase regulates cell adhesion and invasion in human anaplastic large cell lymphoma."}, {"pubmed": 25867765, "text": "CDX2 transcriptionally regulates ST6GalNAc-I gene expression, specifically in the preneoplastic intestinal metaplasia lesion."}, {"pubmed": 26054692, "text": "These results suggest a role for ST6Gal-I to promote the growth and invasion of osteosarcoma cells."}, {"pubmed": 26224120, "text": "Data indicate that O-glycan-specific alpha2,6 sialyltransferase regulate cancer growth and metastasis by regulating galectins Gal-1- and Gal-3-binding moieties on O-glycans."}, {"pubmed": 26258617, "text": "Expression levels of sialyltransferases ST3GAL1 and ST3GAL4 were upregulated in the HRMECs after high-glucose stimulation."}, {"pubmed": 26304831, "text": "Collectively, our data indicate that ST6GAL1 plays an important role in the regulation of pluripotency and differentiation in hPSCs."}, {"pubmed": 26840264, "text": "High ST6GAL1 expression is associated with aging."}, {"pubmed": 27216178, "text": "High ST6GAL1 expression is associated with ovarian and pancreatic Cancers."}, {"pubmed": 27340870, "text": "these results indicate that ST6Gal-I might play a positive role in mediating the survival of human hepatocarcinoma cells"}, {"pubmed": 27510958, "text": "The results demonstrate that epigenetic modulation of ST6Gal1 expression plays a key role in the glioma phenotype in vitro and that that therapeutic approaches targeting elements of the epigenetic machinery for the treatment of human glioblastoma are warranted."}, {"pubmed": 27588482, "text": "these results indicate that ST6Gal-I plays a critical role in cell proliferation and invasion via the PI3K/Akt/GSK-3beta/beta-catenin signaling pathway during cancer progression"}, {"pubmed": 27986075, "text": "Results provide evidence that ST6GAL1 contributes to drug resistance in cervical neoplasm."}, {"pubmed": 28032597, "text": "Suggest a crucial role for ST6Gal1 in elevating the invasiveness of pancreatic ductal adenocarcinoma cells in a fructose-responsive manner."}, {"pubmed": 28154177, "text": "The results presented in this study provide an important advance by highlighting a new function for ST6Gal-I in promoting the viability of tumor cells exposed to the type of serum-depleted conditions often found in hypovascularized tumor microenvironments."}, {"pubmed": 28377225, "text": "Taken together, these results indicate a dynamic change in the expression of ST6GAL1 during the CRC progression and provide a list of sialylated proteins potentially relevant to the different functions of ST6GAL1 in CRC."}, {"pubmed": 28395125, "text": "ST3Gal I and ST6Gal I have different sialic acid donor specificity."}, {"pubmed": 28550122, "text": "The data confirm that circulatory ST6Gal-1 is a negative systemic regulator of granulopoiesis"}, {"pubmed": 28603863, "text": "We discovered three significant associations at rs6679677 on 1p13.2 (P=6.15x10-5, OR=5.07), rs16861329 on 3q27.3 (P=2.02x10-4, OR=0.87) and rs849135 on 7p15.1 (P=6.59x10-9, OR=1.78), which suggested PTPN22, ST6GAL1 and JAZF1 as novel susceptibility genes for psoriasis in Chinese population."}, {"pubmed": 29233887, "text": "by restraining TNFR1 at the cell surface via sialylation, ST6Gal-I acts as a functional switch to divert signaling toward survival. These collective findings point to a novel glycosylation-dependent mechanism that regulates the cellular response to TNF and may promote cancer cell survival within TNF-rich tumor microenvironments."}, {"pubmed": 29475939, "text": "cells grown in hypoxia for several weeks displayed enriched ST6Gal-I expression, consistent with a pro-survival function. Taken together, these findings unravel a glycosylation-dependent mechanism that facilitates tumor cell adaptation to a hypoxic milieu."}, {"pubmed": 29654763, "text": "ST6GAL1 might be a potential target for atherosclerosis prevention and treatment."}, {"pubmed": 29981167, "text": "High ST6Gal-I expression is associated with invasiveness and tumorigenicity of non-small cell lung cancer."}, {"pubmed": 30016515, "text": "High ST6GAL1 mRNA levels significantly correlated with lymphovascular invasion and shorter survival, whereas high ST6GAL1 protein expression was associated with advanced stage, distant metastasis and shorter recurrence-free intervals."}, {"pubmed": 30057317, "text": "The St6gal1 KD contributes more to the HBV life cycle than Mgat2 or Mgat4a KD through the modification of intracellular L, Pol, and HBc expression."}, {"pubmed": 30226606, "text": "Although ST6GalI overexpression increased HER2 sialylation, corresponding to decreased HER2 phosphorylation, high alpha2,6sialylation enhanced Akt and ERK phosphorylation levels compared to those in the vector cell line; ST6GalI knockdown had the opposite effects. Collectively, these results implicated a functional role of ST6GalI in promoting tumor cell progression and trastuzumab resistance."}, {"pubmed": 30730306, "text": "ST6GAL1-induced sialylation of MUC4beta in epithelial dysfunction associated with T2-high asthma, thereby identifying specific sialylation pathways as potential targets in asthma."}, {"pubmed": 30929638, "text": "Genetic Variants in the ST6GAL1 Gene Are Associated with Thyroglobulin Plasma Level in Healthy Individuals."}, {"pubmed": 30972697, "text": "ST6Gal-I promotes the immune escape of hepatocarcinoma cells in the tumor microenvironment and highlight the importance of assessing ST6Gal-I status for immunotherapies."}, {"pubmed": 31317190, "text": "ST6GAL1 expression affected differentially the tyrosine phosphorylation induced by hepatocyte growth factor, the ability to grow in soft agar, to heal a scratch wound and to invade Matrigel in the two cell lines."}, {"pubmed": 31610800, "text": "These data suggest a process whereby SOX2 and ST6GAL1 are coordinately amplified in cancer cells, with the Sox2 protein then binding the ST6GAL1 promoter to further augment ST6Gal-I expression. Our collective results provide new insight into mechanisms that upregulate ST6Gal-I expression in ovarian cancer cells, and also point to the possibility that some of the CSC characteristics commonly attributed to Sox2 may, in part"}, {"pubmed": 31694696, "text": "The HOTAIR/miR-214/ST6GAL1 axis commands the CRC malignancy by modifying c-Met with sialylation and activating JAK2/STAT3 pathway."}, {"pubmed": 31794515, "text": "Influences of two significant variants located in the ST6GAL1 3'-untranslated region on lung carcinoma susceptibility in the Chinese Han population."}, {"pubmed": 32016470, "text": "Sialylation of FGFR1 by ST6GalI overexpression contributes to ovarian cancer cell migration and chemoresistance."}, {"pubmed": 32677771, "text": "ST6Gal1 is up-regulated and associated with aberrant IgA1 glycosylation in IgA nephropathy: An integrated analysis of the transcriptome."}, {"pubmed": 32747022, "text": "ST6GAL1 polymorphisms influence susceptibility and progression of IgA nephropathy in a Chinese Han population."}, {"pubmed": 32763973, "text": "Modulation of glycosyltransferase ST6Gal-I in gastric cancer-derived organoids disrupts homeostatic epithelial cell turnover."}, {"pubmed": 32945502, "text": "Nglycosylation and receptor tyrosine kinase signaling affect claudin3 levels in colorectal cancer cells."}, {"pubmed": 32971290, "text": "Unliganded and CMP-Neu5Ac bound structures of human alpha-2,6-sialyltransferase ST6Gal I at high resolution."}, {"pubmed": 33108606, "text": "Regulation of human beta-galactoside alpha2,6-sialyltransferase (hST6Gal I) gene expression during differentiation of human osteoblastic MG-63 cells."}, {"pubmed": 33148698, "text": "Glycosyltransferase ST6Gal-I promotes the epithelial to mesenchymal transition in pancreatic cancer cells."}, {"pubmed": 33166339, "text": "Regulation of inflammatory signaling by the ST6Gal-I sialyltransferase."}, {"pubmed": 33288659, "text": "ST6GAL1 Is a Novel Serum Biomarker for Lenvatinib-Susceptible FGF19-Driven Hepatocellular Carcinoma."}, {"pubmed": 33320246, "text": "Regulation of ST6GAL1 sialyltransferase expression in cancer cells."}, {"pubmed": 33836687, "text": "Association of ST6GAL1 and CYP19A1 polymorphisms in the 3'-UTR with astrocytoma risk and prognosis in a Chinese Han population."}, {"pubmed": 33947960, "text": "ST6Gal1 targets the ectodomain of ErbB2 in a site-specific manner and regulates gastric cancer cell sensitivity to trastuzumab."}, {"pubmed": 34290711, "text": "ST6GAL1 and alpha2-6 Sialylation Regulates IL-6 Expression and Secretion in Chronic Obstructive Pulmonary Disease."}, {"pubmed": 35041825, "text": "Sialyltransferase ST6GAL-1 mediates resistance to chemoradiation in rectal cancer."}, {"pubmed": 35157848, "text": "ST6Gal-I-mediated sialylation of the epidermal growth factor receptor modulates cell mechanics and enhances invasion."}, {"pubmed": 35467766, "text": "Genetic variation in ST6GAL1 is a determinant of capecitabine and oxaliplatin induced hand-foot syndrome."}, {"pubmed": 35661210, "text": "Extracellular ST6GAL1 regulates monocyte-macrophage development and survival."}, {"pubmed": 35676533, "text": "Extracellular sialyltransferase st6gal1 in breast tumor cell growth and invasiveness."}, {"pubmed": 36528750, "text": "ST6GAL1 inhibits metastasis of hepatocellular carcinoma via modulating sialylation of MCAM on cell surface."}, {"pubmed": 36646912, "text": "Role of ST6GAL1 and ST6GAL2 in subversion of cellular signaling during enteroaggregative Escherichia coli infection of human intestinal epithelial cell lines."}, {"pubmed": 37326830, "text": "CCCTC-binding factor: the specific transcription factor of beta-galactoside alpha-2,6-sialyltransferase 1 that upregulates the sialylation of anti-citrullinated protein antibodies in rheumatoid arthritis."}, {"pubmed": 37364046, "text": "Role of the ST6GAL1 sialyltransferase in regulating ovarian cancer cell metabolism."}, {"pubmed": 37550801, "text": "ST6GAL1-mediated aberrant sialylation promotes prostate cancer progression."}, {"pubmed": 37643018, "text": "ST6GAL1 sialyltransferase promotes acinar to ductal metaplasia and pancreatic cancer progression."}, {"pubmed": 37660914, "text": "Sialylation of EGFR by ST6GAL1 induces receptor activation and modulates trafficking dynamics."}, {"pubmed": 38003522, "text": "Role of ST6GAL1 in Thyroid Cancers: Insights from Tissue Analysis and Genomic Datasets."}, {"pubmed": 38490094, "text": "N-linked alpha2,6-sialylation of integrin beta1 by the sialyltransferase ST6Gal1 promotes cell proliferation and stemness in gestational trophoblastic disease."}], "genomic_pos": {"chr": "3", "end": 187078553, "ensemblgene": "ENSG00000073849", "start": 186930325, "strand": 1}, "genomic_pos_hg19": {"chr": "3", "end": 186796341, "start": 186648274, "strand": 1}, "go": {"BP": [{"evidence": "IDA", "gocategory": "BP", "id": "GO:0006054", "pubmed": 23999306, "qualifier": "involved_in", "term": "N-acetylneuraminate metabolic process"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0006959", "pubmed": 7786324, "qualifier": "involved_in", "term": "humoral immune response"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0016266", "qualifier": "involved_in", "term": "O-glycan processing"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0018279", "qualifier": "involved_in", "term": "protein N-linked glycosylation via asparagine"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0018279", "pubmed": 23999306, "qualifier": "involved_in", "term": "protein N-linked glycosylation via asparagine"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0019082", "qualifier": "involved_in", "term": "viral protein processing"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0032946", "qualifier": "involved_in", "term": "positive regulation of mononuclear cell proliferation"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0045471", "qualifier": "involved_in", "term": "response to ethanol"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0050922", "qualifier": "involved_in", "term": "negative regulation of chemotaxis"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0097503", "qualifier": "involved_in", "term": "sialylation"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0097503", "pubmed": 23999306, "qualifier": "involved_in", "term": "sialylation"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:1900024", "qualifier": "involved_in", "term": "regulation of substrate adhesion-dependent cell spreading"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:2000110", "qualifier": "involved_in", "term": "negative regulation of macrophage apoptotic process"}], "CC": [{"evidence": "IEA", "gocategory": "CC", "id": "GO:0000138", "qualifier": "located_in", "term": "Golgi trans cisterna"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0000139", "pubmed": 20378551, "qualifier": "located_in", "term": "Golgi membrane"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0000139", "qualifier": "located_in", "term": "Golgi membrane"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0005576", "qualifier": "located_in", "term": "extracellular region"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0005794", "qualifier": "is_active_in", "term": "Golgi apparatus"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0005797", "qualifier": "located_in", "term": "Golgi medial cisterna"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0032580", "qualifier": "located_in", "term": "Golgi cisterna membrane"}], "MF": [{"category": "MF", "evidence": "IBA", "id": "GO:0003835", "qualifier": "enables", "term": "beta-galactoside alpha-2,6-sialyltransferase activity"}, {"category": "MF", "evidence": "IDA", "id": "GO:0003835", "pubmed": 23999306, "qualifier": "enables", "term": "beta-galactoside alpha-2,6-sialyltransferase activity"}, {"category": "MF", "evidence": "TAS", "id": "GO:0003835", "qualifier": "enables", "term": "beta-galactoside alpha-2,6-sialyltransferase activity"}, {"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": 16237761, "qualifier": "enables", "term": "protein binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0008373", "pubmed": 21081508, "qualifier": "enables", "term": "sialyltransferase activity"}, {"category": "MF", "evidence": "TAS", "id": "GO:0008373", "qualifier": "enables", "term": "sialyltransferase activity"}, {"category": "MF", "evidence": "IDA", "id": "GO:0042803", "pubmed": 20378551, "qualifier": "enables", "term": "protein homodimerization activity"}]}, "homologene": {"genes": [[7955, 445376], [8364, 100491268], [9031, 396169], [9544, 708113], [9598, 460922], [9606, 6480], [9615, 478668], [9913, 282073], [10090, 20440], [10116, 25197]], "id": 2281}, "interpro": [{"desc": "GT29-like superfamiliy", "id": "IPR038578", "short_desc": "GT29-like_sf"}, {"desc": "Glycosyl transferase family 29", "id": "IPR001675", "short_desc": "Glyco_trans_29"}, {"desc": "Sialyltransferase", "id": "IPR012163", "short_desc": "Sialyl_trans"}], "ipi": ["IPI00013887", "IPI00376240", "IPI00924563", "IPI00924805", "IPI00924988", "IPI00925201", "IPI00926637", "IPI00926833", "IPI00926861", "IPI00927060", "IPI00927347", "IPI00927588", "IPI00927798"], "map_location": "3q27.3", "name": "ST6 beta-galactoside alpha-2,6-sialyltransferase 1", "other_names": ["B-cell antigen CD75", "CMP-N-acetylneuraminate beta-galactosamide alpha-2,6-sialyltransferase", "CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,6-sialyltransferase 1", "ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 1", "ST6 beta-galactosamide alpha-2,6-sialyltranferase 1", "alpha 2,6-ST 1", "beta-galactoside alpha-2,6-sialyltransferase 1", "sialyltransferase 1 (beta-galactoside alpha-2,6-sialyltransferase)"], "pantherdb": {"HGNC": "10860", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "108470", "ortholog_type": "LDO", "panther_family": "PTHR46059", "taxid": 10090, "uniprot_kb": "Q64685"}, {"RGD": "3676", "ortholog_type": "LDO", "panther_family": "PTHR46059", "taxid": 10116, "uniprot_kb": "P13721"}, {"Ensembl": "ENSGALG00000005550", "ortholog_type": "LDO", "panther_family": "PTHR46059", "taxid": 9031, "uniprot_kb": "F1NRE4"}, {"Gene": "ST6GAL1", "ortholog_type": "LDO", "panther_family": "PTHR46059", "taxid": 9031, "uniprot_kb": "Q92182"}, {"FlyBase": "FBgn0035050", "ortholog_type": "LDO", "panther_family": "PTHR46059", "taxid": 7227, "uniprot_kb": "Q9GU23"}], "uniprot_kb": "P15907"}, "pathway": {"humancyc": {"id": "PWY-7434", "name": "terminal <i>O</i>-glycans residues modification"}, "kegg": [{"id": "hsa00510", "name": "N-Glycan biosynthesis - Homo sapiens (human)"}, {"id": "hsa00514", "name": "Other types of O-glycan biosynthesis - Homo sapiens (human)"}], "reactome": [{"id": "R-HSA-1643685", "name": "Disease"}, {"id": "R-HSA-1643685", "name": "Disease"}, {"id": "R-HSA-392499", "name": "Metabolism of proteins"}, {"id": "R-HSA-4085001", "name": "Sialic acid metabolism"}, {"id": "R-HSA-446193", "name": "Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein"}, {"id": "R-HSA-446203", "name": "Asparagine N-linked glycosylation"}, {"id": "R-HSA-446219", "name": "Synthesis of substrates in N-glycan biosythesis"}, {"id": "R-HSA-5173105", "name": "O-linked glycosylation"}, {"id": "R-HSA-5663205", "name": "Infectious disease"}, {"id": "R-HSA-5663205", "name": "Infectious disease"}, {"id": "R-HSA-597592", "name": "Post-translational protein modification"}, {"id": "R-HSA-913709", "name": "O-linked glycosylation of mucins"}, {"id": "R-HSA-948021", "name": "Transport to the Golgi and subsequent modification"}, {"id": "R-HSA-9678108", "name": "SARS-CoV-1 Infection"}, {"id": "R-HSA-9679506", "name": "SARS-CoV Infections"}, {"id": "R-HSA-9679506", "name": "SARS-CoV Infections"}, {"id": "R-HSA-9683673", "name": "Maturation of protein 3a"}, {"id": "R-HSA-9683701", "name": "Translation of Structural Proteins"}, {"id": "R-HSA-9694516", "name": "SARS-CoV-2 Infection"}, {"id": "R-HSA-9694516", "name": "SARS-CoV-2 Infection"}, {"id": "R-HSA-9694548", "name": "Maturation of spike protein"}, {"id": "R-HSA-9694635", "name": "Translation of Structural Proteins"}, {"id": "R-HSA-9694635", "name": "Translation of Structural Proteins"}, {"id": "R-HSA-9694719", "name": "Maturation of protein 3a"}, {"id": "R-HSA-975576", "name": "N-glycan antennae elongation in the medial/trans-Golgi"}, {"id": "R-HSA-975577", "name": "N-Glycan antennae elongation"}, {"id": "R-HSA-977068", "name": "Termination of O-glycan biosynthesis"}, {"id": "R-HSA-9772573", "name": "Late SARS-CoV-2 Infection Events"}, {"id": "R-HSA-9772573", "name": "Late SARS-CoV-2 Infection Events"}, {"id": "R-HSA-9824446", "name": "Viral Infection Pathways"}, {"id": "R-HSA-9824446", "name": "Viral Infection Pathways"}], "wikipathways": {"id": "WP1424", "name": "Globo Sphingolipid Metabolism"}}, "pdb": ["4JS1", "4JS2", "6QVS", "6QVT"], "pfam": "PF00777", "pharmgkb": "PA35762", "pharos": {"target_id": 7793, "tdl": "Tchem"}, "pir": "A41734", "reagent": {"CM-LibrX-no-seq": [{"id": "GNF326183", "relationship": "is"}, {"id": "GNF326184", "relationship": "is"}, {"id": "GNF326185", "relationship": "is"}], "CondMedia_CM_LibrAB": [{"id": "GNF292778", "relationship": "is"}, {"id": "GNF292888", "relationship": "is"}, {"id": "GNF293278", "relationship": "is"}], "GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF176877", "relationship": "is"}, {"id": "GNF187783", "relationship": "is"}, {"id": "GNF198689", "relationship": "is"}, {"id": "GNF209595", "relationship": "is"}], "GNF_hs-Origene": {"id": "GNF046126", "relationship": "is"}, "GNF_mm+hs-MGC": [{"id": "GNF013357", "relationship": "is"}, {"id": "GNF013358", "relationship": "is"}], "GNF_mm+hs_RetroCDNA": {"id": "GNF239178", "relationship": "is"}, "MasterSecretomicsList": [{"id": "GNF330461", "relationship": "is"}, {"id": "GNF331767", "relationship": "is"}, {"id": "GNF333554", "relationship": "is"}], "NIBRI_hs-Secretome_pDEST": [{"id": "GNF336966", "relationship": "is"}, {"id": "GNF338364", "relationship": "is"}], "NOVART_hs-genome_siRNA": [{"id": "GNF103396", "relationship": "is"}, {"id": "GNF143046", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000003.12", "NC_060927.1"], "protein": ["NP_001340845.1", "NP_003023.1", "NP_775323.1", "NP_775324.1"], "rna": ["NM_001353916.2", "NM_003032.3", "NM_173216.2", "NM_173217.2"], "translation": [{"protein": "NP_001340845.1", "rna": "NM_001353916.2"}, {"protein": "NP_775324.1", "rna": "NM_173217.2"}, {"protein": "NP_003023.1", "rna": "NM_003032.3"}, {"protein": "NP_775323.1", "rna": "NM_173216.2"}]}, "reporter": {"HG-U133_Plus_2": ["201998_at", "214970_s_at", "214971_s_at"], "HG-U95Av2": "41352_at", "HTA-2_0": ["TC03001028.hg.1", "TC03002711.hg.1"], "HuEx-1_0": "2656837", "HuGene-1_1": "8084717", "HuGene-2_1": "16949403"}, "retired": 102723861, "summary": "This gene encodes a member of glycosyltransferase family 29. The encoded protein is a type II membrane protein that catalyzes the transfer of sialic acid from CMP-sialic acid to galactose-containing substrates. The protein, which is normally found in the Golgi but can be proteolytically processed to a soluble form, is involved in the generation of the cell-surface carbohydrate determinants and differentiation antigens HB-6, CD75, and CD76. This gene has been incorrectly referred to as CD75. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2017].", "symbol": "ST6GAL1", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1539865"}, "unigene": "Hs.207459", "uniprot": {"Swiss-Prot": "P15907", "TrEMBL": ["C9JPG6", "C9IYS8", "C9JVK7", "C9JFM4", "C9JI90", "C9J6X5", "H7C472", "C9JH16", "C9JTR0", "C9K0R8", "C9JR47", "C9JAT4"]}, "wikipedia": {"url_stub": "ST6GAL1"}}